Senior insider sale
Chief Commercial Officer at ABEONA THERAPEUTICS INC. — senior position signals high conviction
$172.4K
27.77K shares
What this filing means
VASANTHAVADA MADHAV plans to sell 27.77K shares of ABEONA THERAPEUTICS INC. valued at approximately $172.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/9/2026ACC: 0001972481-26-000231
Officer· Chief Commercial Officer
Since Jan 2026
27.77K
Shares to sell
$172.4K
Approx. market value
28.52K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Awards
Equity Compensation
7/8/2026
28.52KTotal acquired28.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2026 | Restricted Stock Awards Equity Compensation | 28.52K | — |
| Total | 28.52K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
5.45K
Market value
$28.9K
6/9/2026
—Completed
Units to sell
4.17K
Market value
$22.6K
6/8/2026
—Completed
Units to sell
5.55K
Market value
$33.1K
5/11/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
12.61K
Market value
$87.8K
7/9/2026
Total
Units
27.77K
Value
$172.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/9/2026 | 5.45K | $28.9K | — | Completed |
6/8/2026 | 4.17K | $22.6K | — | Completed |
5/11/2026 | 5.55K | $33.1K | — | Completed |
| Planned — Approximate Date | ||||
7/9/2026 | 12.61K | $87.8K | Nasdaq | Planned |
| Total | 27.77K | $172.4K | ||